Filing Details
- Accession Number:
- 0001209191-19-018294
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-08 19:30:34
- Reporting Period:
- 2019-03-08
- Accepted Time:
- 2019-03-08 19:30:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1610618 | Cidara Therapeutics Inc. | CDTX | Biological Products, (No Disgnostic Substances) (2836) | 461537286 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1678223 | Neil Abdollahian | 6310 Nancy Ridge Dr Suite 101 San Diego CA 92121 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-03-08 | 2,300 | $2.44 | 30,472 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold to cover the tax obligation that occurred upon the vesting of restricted stock units.
Billionaire Hedge Funds
